RT @MCR_AACR: Want to read about drug targets at #AACR22? Check out, Chk1 Inhibition Potently Blocks #STAT3 Tyrosine705 Phosphorylation, DN…

Want to read about drug targets at #AACR22? Check out, Chk1 Inhibition Potently Blocks #STAT3 Tyrosine705 Phosphorylation, DNA-Binding Activity, and Activation of Downstream Targets in Human #MultipleMyeloma Cells by Zhou, Grant and colleagues. https://t.c

The authors of "Chk1 Inhibition Potently Blocks STAT3 Tyrosine705…" (https://t.co/6plsAZyC97) included RRIDs in their paper! RRIDs like this improve reproducibility in scientific research. #OpenScience #ReproducibleResearch

#ICYMI: Chk1 inhibition blocks STAT3 tyrosine705 phosphorylation, DNA binding activity, and activation of downstream targets in human #MultipleMyeloma cells. Zhou et al describe this link between Chk1 and STAT3. https://t.co/zGRN2cGeyE https://t.co/fB6J4fz

Chk1 inhibition blocks STAT3 tyrosine705 phosphorylation, DNA binding activity, and activation of downstream targets in human #MultipleMyeloma cells. Zhou et al describe this link between Chk1 and STAT3. https://t.co/weTUK0LFCS https://t.co/oJwm6jXT9N

RT @MCR_AACR: Chk1 inhibition blocks STAT3 tyrosine705 phosphorylation, DNA binding activity, and activation of downstream targets in human…

RT @MCR_AACR: Chk1 inhibition blocks STAT3 tyrosine705 phosphorylation, DNA binding activity, and activation of downstream targets in human…

Chk1 inhibition blocks STAT3 tyrosine705 phosphorylation, DNA binding activity, and activation of downstream targets in human #MultipleMyeloma cells. Zhou et al describe this link between Chk1 and STAT3. https://t.co/aVaCbOUgzj https://t.co/lZsJIZlz9I

New article: Chk1 inhibition potently blocks STAT3 tyrosine705 phosphorylation, DNA binding activity, and activation of downstream targets in human multiple myeloma cells https://t.co/JAiz4nX8ur #MMSM #MultipleMyeloma #hematology https://t.co/thhmZgaiKC